Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 4, 2006, Pages

  Li, Tao Sheng ^a   Furutani, Akira ^a   Takahashi, Masaya ^a   Ohshima, Mako ^a   Qin, Shu Lan ^a   Kobayashi, Toshiro ^a   Ito, Hiroshi ^a   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT2A receptor; Blood flow; Diabetes; Hyperlipidemia; Ischemia

Indexed keywords

SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETES MELLITUS; HYPERLIPIDEMIA; MALE; MONONUCLEAR CELL; MUSCLE ISCHEMIA; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL; ANIMAL; DIABETIC ANGIOPATHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; ZUCKER RAT;

ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; HYPERLIPIDEMIAS; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; RATS; RATS, ZUCKER; TREATMENT OUTCOME;

EID: 33646108612     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00766.2005     Document Type: Article

References (27)

1. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, and Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-3017, 2002.
2. Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Rossig L, Spyridopoulos I, Zeiher AM, and Dimmeler S. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 92: 1049-1055, 2003.
3. Barrabas MA, Gill DS, Fonseca VA, Mikhailidis DP, and Dandona P. Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest 18: 399-404, 1988.
4. Esato K, Hamano K, Li TS, Furutani A, Seyama A, Takenaka H, and Zempo N. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 11: 747-752, 2002.
5. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, Waksman R, Weissman NJ, Cerqueira M, Leon MB, and Epstein SE. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 41: 1721-1724, 2003.
6. Hamano K, Li TS, Kobayashi T, Tanaka N, Kobayashi S, Matsuzaki M, and Esato K. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. Surgery 130: 44-54, 2001.
7. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, and Esato K. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 65: 845-847, 2001.
8. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, and Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615-1622, 2004.
9. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
10. Janiak P, Lainee P, Grataloup Y, Luyt CE, Bidouard JP, Michel JB, O'Connor SE, and Herbert JM. Serotonin receptor blockade improves distal perfusion after lower limb ischemia in the fatty Zucker rat. Cardiovasc Res 56: 293-302, 2002.
11. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, and Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436, 2001.
12. + stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol 285: H931-H937, 2003.
13. Li TS, Hamano K, Suzuki K, Ito H, Zempo N, and Matsuzaki M. Improved angiogenic potency by implantation of ex vivo hypoxia pre-stimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol 283: H468-H473, 2002.
14. 2 in reducing collateral blood flow by activated platelets. Am J Physiol Heart Circ Physiol 265: H158-H164, 1993.
15. Malyszko J, Urano T, Knofler R, Taminato A, Yoshimi T, Takada Y, and Takada A. Daily variations of platelets aggregation in relation to blood and plasma serotonin in diabetes. Thromb Res 75: 569-576, 1994.
16. Murasawa S, Llevadot J, Silver M, Isner JM, Losordo DW, and Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106: 1133-1139, 2002.
17. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, and Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107: 2294-2302, 2003.
18. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, and Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106: 571-578, 2000.
19. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, and Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46, 2003.
20. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, and Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918, 2002.
21. Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, Barateau V, Lecomte-Raclet L, Clergue M, Duriez M, Tobelem G, and Levy BI. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 164: 457-466, 2004.
22. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, and Imaizumi T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360: 427-435, 2002.
23. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, and Gurtner GC. Human endothelial progenitor cells from Type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786, 2002.
24. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, and Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361: 47-49, 2003.
25. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7, 2001.
26. Verheyen A, Lauwers F, Vlaminckx E, Wouters L, and de Clerck F. Oversensitivity to serotonin of the collateralized vascular bed in rat hindquarters: mechanisms of increased vasoconstriction. Eur J Pharmacol 194: 209-216, 1991.
27. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49: 554-560, 2001.